Black Rock Inc. T2 Biosystems, Inc. Transaction History

Black Rock Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.09 - $565.0 $206 - $1.3 Million	-2,296 Reduced 0.09%	2,564,299 $290,000
Q2 2022 Aug 12, 2022	SELL	$0.15 - $0.54 $52,003 - $187,212	-346,690 Reduced 11.9%	2,566,595 $415,000
Q1 2022 May 12, 2022	BUY	$0.36 - $0.57 $361 - $572	1,004 Added 0.03%	2,913,285 $1.53 Million
Q4 2021 Feb 10, 2022	SELL	$0.46 - $0.94 $12,918 - $26,398	-28,083 Reduced 0.96%	2,912,281 $1.5 Million
Q3 2021 Nov 09, 2021	SELL	$0.86 - $1.21 $27,630 - $38,874	-32,128 Reduced 1.08%	2,940,364 $2.69 Million
Q2 2021 Aug 11, 2021	BUY	$1.04 - $1.69 $3.09 Million - $5.02 Million	2,972,492 New	2,972,492 $3.54 Million

Ticker TTOO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 7,050,850
Market Cap $15.9M
Description
T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fl...

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

Stay updated on Black Rock Inc. with notifications on news.